Cawachi Limited
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2017/01/24 | ¥52.87 | ¥43.58 | -17.6% |
| 2016/07/26 | ¥41.60 | ¥44.54 | +7.1% |
| 2016/01/26 | ¥43.26 | ¥30.64 | -29.2% |
| 2015/07/23 | ¥38.06 | ¥39.50 | +3.8% |
Shareholder Composition
Updated 2026/10/01Dividend History 1Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥150 | +87.5% |
| 2025 | ¥80 | 0.0% |
| 2024 | ¥80 | +60.0% |
| 2023 | ¥50 | 0.0% |
| 2022 | ¥50 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥281,871M | ¥285,960M | ¥287,816M | ¥284,492M |
| Gross Profit | ¥64,047M | ¥65,801M | ¥66,717M | ¥65,318M |
| Operating Income | ¥6,612M | ¥7,601M | ¥7,461M | ¥6,780M |
| Pretax Income | ¥6,613M | ¥7,188M | ¥6,863M | ¥5,642M |
| Net Income | ¥4,177M | ¥4,713M | ¥4,884M | ¥3,200M |
| EPS | ¥186.85 | ¥210.79 | ¥218.48 | ¥143.14 |
| Operating Margin | 2.35% | 2.66% | 2.59% | 2.38% |
| Balance Sheet | ||||
| Total Assets | ¥194,496M | ¥196,119M | ¥199,601M | ¥199,614M |
| Total Equity | ¥107,724M | ¥111,292M | ¥114,408M | ¥115,925M |
| Total Liabilities | ¥86,772M | ¥84,827M | ¥85,193M | ¥83,689M |
| Cash | ¥38,450M | ¥35,623M | ¥36,674M | ¥38,112M |
| Interest-bearing Debt | ¥19,549M | ¥16,729M | ¥16,599M | ¥16,114M |
| Equity Ratio | 55.39% | 56.75% | 57.32% | 58.07% |
| D/E Ratio | 0.18 | 0.15 | 0.15 | 0.14 |
| Cash Flow | ||||
| Operating CF | ¥9,817M | ¥6,402M | ¥7,481M | ¥8,865M |
| Investing CF | -¥5,840M | -¥5,291M | -¥4,515M | -¥5,156M |
| Financing CF | -¥4,485M | -¥3,937M | -¥1,915M | -¥2,270M |
| Free CF | ¥4,110M | ¥1,023M | ¥3,221M | ¥4,542M |
| Efficiency | ||||
| ROE | 3.88% | 4.23% | 4.27% | 2.76% |
| ROA | 2.15% | 2.40% | 2.45% | 1.60% |
Latest IR Information
-
Notice Regarding the Results of treasury stock acquisition and the termination of the acquisition
From August 12, 2026 to September 1, 2026, the company acquired 532,400 ordinary shares as treasury stock through market purchases for a total of 1,999,802,000 yen. The upper limit was 700,000 shares (3.13% of issued shares) and up to 2,000,000,000...
Read more -
Notice Regarding Resolution on Share Buyback
Maximum of 700,000 shares to be acquired, up to 3.13% of issued shares, total amount up to 2,000,000,000 yen, during the period from 2026/08/12 to 2026/09/07.
Read more -
【Kawachi Pharmaceuticals】Q1 2027 Earnings｜Sales 71.9 billion yen (+1.3%)
Kawachi Pharmaceuticals achieved sales of 71.9 billion yen (YoY +1.3%), operating profit of 1.447 billion yen (+15.9%), and net income attributable to owners of the parent of 1.12 billion yen (+5.5%) in the first quarter of the fiscal year ending...
Read more -
Fiscal Year Ending March 2026 Financial Summary [Japanese GAAP] (Consolidated)
For the fiscal year ending March 2026, consolidated net sales were JPY 284,492 million (down 1.2% YoY), operating income was JPY 6,779 million (down 9.1% YoY), and net income attributable to owners of parent was JPY 3,200 million (down 34.5%...
Read more -
Notice Regarding the Recording of Extraordinary Loss
In the fiscal year ending March 2026, an impairment loss on fixed assets of 2,117 million yen was recorded as an extraordinary loss and reflected in the financial summary.
Read more
Latest News (5 items)
Company Information
About
Cawachi Limited engages in the management of drugstores in Japan. It offers retail and insurance dispensing of medicines, medical-related products, health foods, childcare products, cosmetics, daily necessities, general foods, and confectionery. The company was founded in 1960 and is headquartered in Oyama, Japan.
